Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

BIO-TECHNE (TECH) Accumulated Depreciation & Amortization: 2010-2025

Historic Accumulated Depreciation & Amortization for BIO-TECHNE (TECH) over the last 15 years, with Sep 2025 value amounting to $289.0 million.

  • BIO-TECHNE's Accumulated Depreciation & Amortization rose 8.94% to $289.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 10.33%. This contributed to the annual value of $286.1 million for FY2025, which is 11.53% up from last year.
  • BIO-TECHNE's Accumulated Depreciation & Amortization amounted to $289.0 million in Q3 2025, which was up 1.00% from $286.1 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Accumulated Depreciation & Amortization peaked at $289.0 million during Q3 2025, and registered a low of $186.9 million during Q1 2021.
  • Over the past 3 years, BIO-TECHNE's median Accumulated Depreciation & Amortization value was $256.6 million (recorded in 2024), while the average stood at $258.9 million.
  • Data for BIO-TECHNE's Accumulated Depreciation & Amortization shows a peak YoY climbed of 12.36% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Accumulated Depreciation & Amortization stood at $201.1 million in 2021, then increased by 11.07% to $223.3 million in 2022, then climbed by 9.79% to $245.2 million in 2023, then climbed by 10.24% to $270.3 million in 2024, then grew by 8.94% to $289.0 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $289.0 million for Q3 2025, versus $286.1 million for Q2 2025 and $278.8 million for Q1 2025.